Therefore, early postoperative application of angiotensin-converting enzyme (ACEI) inhibitors or angiotensin receptor blockers, β-blockers, and mineralocorticoid antagonist has shown to reduce the risk of developing HF and death in patients at high risk of developing HF after MI is important [6–12]. This evidence concerns the gene ACE and hydrops fetalis.